Literature DB >> 17964765

Functional characterization of novel melanocortin-3 receptor mutations identified from obese subjects.

Ya-Xiong Tao1.   

Abstract

It is controversial whether mutation in the melancortin-3 receptor (MC3R) gene is a cause for monogenic obesity in humans. Three novel mutations in the MC3R, A293T, I335S, and X361S, were identified from morbidly obese subjects. We investigated whether these mutations caused loss-of-function and the molecular defects if any. Ligand binding, signaling, and cell surface expression of the mutant MC3Rs were studied. I335S resulted in a complete loss of ligand binding and signaling due to intracellular retention. A293T and X361S MC3Rs had normal ligand binding and signaling as wild type MC3R. Co-expression studies showed that the mutants did not affect wild type MC3R signaling. Hence the I335S variant previously identified from obese patients is not expressed at the cell surface when expressed in vitro, suggesting that it might contribute to obesity in carriers of this variant. Whether A293T and X361S cause obesity remains to be investigated. Additional mutations at I335 showed that I335, part of the highly conserved N/DPxxY motif, was critical for multiple aspects of the MC3R function, including cell surface expression, ligand binding, and signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17964765     DOI: 10.1016/j.bbadis.2007.09.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  22 in total

Review 1.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

2.  Functional studies on twenty novel naturally occurring melanocortin-4 receptor mutations.

Authors:  Zhi-Qiang Wang; Ya-Xiong Tao
Journal:  Biochim Biophys Acta       Date:  2011-06-30

Review 3.  Chaperoning G protein-coupled receptors: from cell biology to therapeutics.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Endocr Rev       Date:  2014-03-24       Impact factor: 19.871

Review 4.  Pharmacoperones as Novel Therapeutics for Diverse Protein Conformational Diseases.

Authors:  Ya-Xiong Tao; P Michael Conn
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

Review 5.  Polymorphisms and mutations in the melanocortin-3 receptor and their relation to human obesity.

Authors:  Andrew P Demidowich; Joo Yun Jun; Jack A Yanovski
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-29       Impact factor: 5.187

Review 6.  Biased signaling at neural melanocortin receptors in regulation of energy homeostasis.

Authors:  Li-Kun Yang; Ya-Xiong Tao
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-04-19       Impact factor: 5.187

7.  Prolylcarboxypeptidase (PRCP) as a new target for obesity treatment.

Authors:  B Shariat-Madar; D Kolte; A Verlangieri; Z Shariat-Madar
Journal:  Diabetes Metab Syndr Obes       Date:  2010-04       Impact factor: 3.168

8.  Functional characterization of nine novel naturally occurring human melanocortin-3 receptor mutations.

Authors:  Fan Yang; Ya-Xiong Tao
Journal:  Biochim Biophys Acta       Date:  2012-08-03

9.  Functions of DPLIY motif and helix 8 of human melanocortin-3 receptor.

Authors:  Zhao Yang; Zhi-Li Huang; Ya-Xiong Tao
Journal:  J Mol Endocrinol       Date:  2015-07-28       Impact factor: 5.098

10.  Melanocortin 3 receptor has a 5' exon that directs translation of apically localized protein from the second in-frame ATG.

Authors:  Jeenah Park; Neeraj Sharma; Garry R Cutting
Journal:  Mol Endocrinol       Date:  2014-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.